Quick ReadPlain-language overview · read this first
Texas Instruments ranks first globally in analog and embedded processors. The current price is USD 309.21, with TTM PE at 52.9x. Rating: Watch.
75% of revenue is exposed to industrial, automotive, and data-center markets, while in-house 300mm manufacturing plus 80% direct sales form a real moat. But operating margin has fallen from 50.6% in 2022 to 34.1%. Excluding CHIPS incentives, Owner Earnings are only USD 4.3-4.6 billion, implying a P/OE as high as 61-66x; earnings yield is 1.89% and FCF yield is 1.54%, both below the 10-year U.S. Treasury yield of 4.57%. Verdict: a good company, not a good price.
DCF neutral intrinsic value is USD 130-180, with an ideal Buy range of USD 100-140, so the current share price carries a clear premium. Add the USD 7.5 billion Silicon Labs acquisition, 12% exposure to a single customer, and 50% of goods entering China, and if valuation normalizes while FCF recovers less than expected, a permanent drawdown of 40%-60% is not hard to imagine.
LeadTXN is the global leader in analog and embedded processors, with 75% of revenue from industrial, automotive, and data center markets and a self-owned 300mm manufacturing base. At roughly $309, the stock trades at about 52.9x PE, well above my intrinsic value range, while the benefits of 300mm manufacturing and acquisition synergies still need proof. Research rating Watch: a high-quality compounder deserves patience, but the current price leaves too little margin of safety.
Prices in the article are as of publication; see the valuation band above for the live price.
Conclusion First
Here is the one-sentence conclusion: TXN is very likely a high-quality business you would be willing to own for the long term, but near the roughly $309.21 per share price around May 23, 2026, it looks more like "excellent company + expensive price" than "excellent company + cheap price." Its current market capitalization is about $282.6 billion, and the market price already embeds a great deal of optimism around recovery in industrial, automotive, and data center demand, realization of 300mm cost advantages, and free-cash-flow leverage after the CapEx cycle rolls over.
Labeling note: I will distinguish as much as possible between 【Fact】 company disclosures or authoritative data; 【Assumption】 valuation parameters; 【Inference】 calculations based on facts; and 【View】 investment judgment. Where I cannot confirm something with high confidence, I will explicitly write "unknown" or "additional information needed."
| Item | Preliminary conclusion |
|---|---|
| Investment rating | Watch |
| Core judgment | The business is understandable, quality is very high, and the moat is real, but the current valuation lacks sufficient margin of safety. |
| Does the current price offer a margin of safety? | Not obvious; I lean no |
| Suitable investor type | Long-term value investors and quality-company investors willing to wait for a good price; not suitable for investors who equate "good company" with "buy now" |
| Biggest uncertainty | The true extent of FCF recovery after CapEx declines; whether data center/industrial demand can offset the semiconductor cycle; integration and financing impact from the Silicon Labs acquisition |
Core judgment: First, TXN's business is among the more "understandable" categories within semiconductors: analog chips and embedded processors, with long product lives, diversified customers, low per-chip value, but critical positions inside systems. Second, it is indeed a good business: in 2025, about 95% of revenue came from analog and embedded, and about 75% was exposed to industrial, automotive, and data center markets where semiconductor content should rise over time; its advantages in 300mm, owned manufacturing, direct sales channels, and an extremely broad product portfolio are also real and verifiable. Third, the main issue is not the business, but the price: at the current share price, TXN's TTM P/E is about 52.9x, and my conservative estimate puts P/Owner Earnings above 60x; its earnings yield and free-cash-flow yield are both below the S&P 500 earnings yield and the 10-year Treasury yield, which is not friendly to "balanced but conservative, 10-year-plus" capital.
The reason not to buy must be stated upfront: If you buy TXN today, the biggest risk is not that "the company deteriorates," but that you paid too high a price for a good company. If the next 3 to 5 years bring only "normalization" rather than "upside surprise," such as margin recovery falling short of market expectations, valuation multiples coming down from elevated levels, or SiLabs synergies materializing more slowly than expected, shareholders may still significantly underperform indices and bonds even if the company itself remains excellent.
Business Understanding and Industry Structure
How This Company Makes Money
【Fact】TXN designs, manufactures, and sells semiconductors, mainly through two reportable segments: Analog and Embedded Processing. In 2025, Analog contributed about 79% of revenue, Embedded Processing about 15%, and the rest came from "Other" businesses such as DLP, calculators, and certain ASICs. Total 2025 revenue was $17.682 billion; Q1 2026 revenue was $4.825 billion.
【Fact】By 2025 end market, industrial accounted for about 33%, automotive about 33%, data center about 9%, personal electronics about 21%, communications equipment about 3%, and calculators about 1%. The company has clearly stated that its strategic focus is analog and embedded, and that it views industrial, automotive, and data center as the best long-term growth directions.
【Fact】TXN has more than 100,000 customers and a broad customer base; the company says roughly half of its revenue comes from outside its largest 50 customers. In 2025, more than 80% of revenue came through direct channels, including TI.com. At the same time, there was indeed one end customer accounting for 12% of revenue in 2025, also 12% in 2024; in 2023, no end customer exceeded 10%. The prospectus/annual report did not disclose that customer's name, so its specific identity is unknown externally.
【View】This means TXN's revenue has both "recurring" and "cyclical" elements. Recurrence comes from products used widely in long-life equipment, design wins that often last many years after qualification, generally long analog chip life cycles, and embedded customers that tend to reuse platforms after investing in their own software. Cyclicality comes from the semiconductor industry's natural inventory upswings and downswings, and from TXN's high proportion of owned fabs, heavy fixed costs, and margin sensitivity to capacity utilization. It is not utility-like stability, but within semiconductors, it is already a relatively predictable sub-industry.
【Fact】On cost structure, TXN has a high share of owned manufacturing. The company emphasizes "doing most manufacturing internally" and treats manufacturing and process technology as core competitive advantages. Its 10-K explicitly states that the cost of unpackaged chips on 300mm wafers is about 40% lower than on 200mm wafers; at the same time, because the company owns a large amount of manufacturing capacity, a meaningful part of its cost base is fixed, so margins are pressured when factory loading declines, and vice versa.
【View】If the stock market were closed for 5 years, I would be willing to own TXN's business, provided the purchase price were reasonable. The reason is that this is a long-term "component platform" company serving industrial, automotive, and foundational electronic equipment, rather than a company dependent on a single blockbuster product or one technology window. What truly makes me hesitate is not the business, but unfortunately the current price.
Business understandability score: 4.5/5.
Industry Stage and Competitive Structure
【Fact】TXN describes the analog and embedded processing markets in its 10-K as "highly fragmented," even after industry consolidation. In Gartner's June 2025 summary of 2024 market share, it wrote that global analog and mixed-signal semiconductor revenue fell 4.2% year over year to $79.7 billion in 2024, and Texas Instruments remained in the number-one position. This shows that TXN operates in a mature, fragmented market where leading share is highly valuable.
【Fact】The broader semiconductor industry is in a recovery cycle. WSTS's fall 2025 forecast expects the global semiconductor market to approach $975 billion in 2026, but growth is mainly driven by memory and logic, while other categories, including analog, are more in "moderate recovery"; in May 2026, SIA stated that global chip sales in Q1 2026 rose 25% sequentially from Q4 2025 and said the industry still had a chance to approach $1 trillion in 2026.
【View】So TXN's industry is not a "permanently booming high-growth industry," but a mature cyclical industry with long-term upward demand. Long-term demand comes from electrification, rising automotive semiconductor content, industrial automation, power management, and data center power and thermal management. Short-term volatility comes from inventories, macro conditions, and capital expenditure cycles. For value investors, this means you cannot simply annualize trough-cycle earnings, and you cannot treat the valuation premium after a cyclical improvement as a margin of safety.
【Fact】Major competitors include Analog Devices, NXP, Microchip, onsemi, Infineon, STMicroelectronics, and Renesas. Based on current share prices, ADI is about $397.07, with a market capitalization of about $194.7 billion; NXPI is about $316.47, with a market capitalization of about $80.2 billion; MCHP is about $93.43, with a market capitalization of about $51.0 billion.
【View】TXN's true distinguishing feature in the industry is not purely "the most advanced technology," but very broad products + owned manufacturing + low-cost 300mm + direct sales channels + long-life customer design wins. That makes it look more like a long-term compounding machine than a leading-edge technology company chasing process nodes. In other words, it is a top-tier company in one of the better semiconductor tracks, but the track itself still carries cyclicality and technology substitution pressure, so it should not be granted a "consumer-staples-like perpetual high valuation" without thought.
Industry attractiveness score: 3.5/5.
Moat and Management
Moat Analysis
【Fact】TXN explicitly summarizes its business model around four sustainable competitive advantages: manufacturing and technology, a broad analog and embedded product portfolio, market channel reach, and diversity and longevity of product/market/customer positions. In 2025, the company had more than 80,000 products and continued launching hundreds of new products; about 95% of 2025 revenue came from analog and embedded, and about 75% from industrial, automotive, and data center.
【View】If we apply your "Buffett-style" framework item by item:
Brand advantage: moderately strong. This is not a consumer brand, but a technical/supply brand at the engineer and OEM level.
Cost advantage: strong. The 300mm cost advantage, owned manufacturing, a future plan to have >95% of wafers internally fabricated before 2030, and >80% of that on 300mm are among the hardest parts of the moat.
Scale advantage: strong. Extremely broad SKUs, global operations, and direct reach to 100,000+ customers.
Network effects: weak. This is not a platform network-effects business.
Switching costs: moderate. Especially in Embedded Processing, customers' software investment tends to extend relationships; analog devices also often have stickiness through certification, BOM, and design validation.
Channel advantage: strong. Direct revenue rose from about one-third in 2019 to over 80% in 2025, and that change matters.
Patent/license/regulatory barriers: moderate. The company owns a large patent portfolio, but it also clearly states that it does not depend on any single patent.
Data advantage: weak to moderate. Not a core moat.
Corporate culture and operating capability: strong. The language of "operating like long-term owners" runs through CEO annual letters, IR pages, and capital management materials.
Capital allocation ability: strong, but not perfect. Long-term dividends, buybacks, and manufacturing investment show continuity; however, the large 2026 acquisition of Silicon Labs still needs verification.
【View】My judgment on the moat is: overall stable, with parts widening. The widening areas are mainly 300mm, owned capacity, direct sales channels, and the industrial/automotive/data center customer mix; what is not necessarily widening is valuation, because the market has already capitalized a large portion of the "moat realization" in advance. For competitors to replicate TXN's combination, they would need not only R&D but also enormous time and capital to build an integrated capability across manufacturing, products, and channels, which usually takes many years or even more than a decade.
【Fact】There is some evidence of pricing power in an inflationary environment. In 2022, the company clearly noted that revenue growth benefited from "higher prices and shipment mix"; meanwhile, even in 2024, under cyclical pressure and depreciation pressure from new capacity, the company still delivered a 34.9% operating margin and $4.799 billion in net income.
【View】Therefore, TXN's historical high margins reflected both structural advantages and the benefits of the cycle and the old depreciation cycle. I would not treat the >48% to 50% operating margins of 2021-2022 as a perpetual norm; but I also would not treat the roughly 34% operating margins of 2024-2025 as "moat failure." A more reasonable view is: under a high-fixed-cost, owned-manufacturing system, utilization and depreciation cycles can create large margin swings, but the central tendency remains very high.
Moat strength score: 4.5/5.
Management and Capital Allocation
【Fact】TXN's IR page and capital management materials repeatedly emphasize that the company's operating objective is long-term free cash flow/free cash flow per share growth; 2026 capital management materials show total capital allocated from 2016 to 2025 of about $109.0 billion, and explicitly state that "after incremental investments supporting long-term FCF growth, remaining cash will be returned to shareholders through dividends and repurchases." The company has achieved 22 consecutive years of dividend increases from 2004 to 2025, and its share count declined 47% from 2004 to 2025.
【Fact】Management's alignment with shareholders is not weak. The 2026 Proxy shows CEO Haviv Ilan held about 760,717 shares, Richard Templeton held about 2,680,196 shares, and all directors and executives together held about 5,477,727 shares; the company's stock ownership requirement for the CEO is 6x base salary, and for other executives 3x.
【View】Here, one honest sentence is needed: management credibility is high, but not so high that investors can stop thinking. Their language has been consistent for a long time, and the reports discuss fixed costs, customer concentration, China exposure, and margin pressure from new capacity relatively frankly; but the "hardest question" in capital allocation appears in 2026: the Silicon Labs transaction of about $7.5 billion, all cash, financed with cash plus new debt. Although the company believes it can lift FCF per share by 2030 and expects $450 million of annual synergies within three years, this is still its largest acquisition in more than a decade and requires cross-border regulatory approval and integration execution.
【View】Past capital allocation has generally been excellent: a long-term manufacturing bet on 300mm, dividends to build a shareholder base, buybacks that reduced shares over time, and few large messy acquisitions. But I would not mythologize buyback timing either: the company of course says it repurchases only when DCF value is above the share price, but external investors cannot fully verify the execution precision of "being more aggressive when undervalued"; at least over the past three years, repurchase amounts were not aggressive during a high-valuation period: about $283 million in 2023, $940 million in 2024, and $1.474 billion in 2025, clearly below $3.62 billion in 2022 and earlier peak periods. This cadence is broadly rational.
Management and capital allocation score: 4/5.
Financial Quality and Owner Earnings
Financial Quality Analysis
Start with a high-confidence key financial table. The 2020-2025 data below come from TXN's 2022/2025 Form 10-K; TTM comes from Q1 2026 filings and market data, in billions of dollars, with some ratios marked as 【Inference】.
| Year | Revenue | Gross margin | Operating margin | Net margin | Operating cash flow | CapEx | Reported FCF | CapEx/revenue |
|---|---|---|---|---|---|---|---|---|
| 2020 | 14.46 | 64.1% | 40.8% | 38.7% | 6.14 | 0.65 | 5.49 | 4.5% |
| 2021 | 18.34 | 67.5% | 48.9% | 42.4% | 8.76 | 2.46 | 6.29 | 13.4% |
| 2022 | 20.03 | 68.8% | 50.6% | 43.7% | 8.72 | 2.80 | 5.92 | 14.0% |
| 2023 | 17.52 | 62.9% | 41.8% | 37.2% | 6.42 | 5.07 | 1.35 | 29.0% |
| 2024 | 15.64 | 58.1% | 34.9% | 30.7% | 6.32 | 4.82 | 1.50 | 30.8% |
| 2025 | 17.68 | 57.0% | 34.1% | 28.3% | 7.15 | 4.55 | 2.94 | 25.7% |
| TTM to 2026Q1 | 18.44 | 57.3% | 35.3% | 29.1% | 7.82 | about 4.10 | about 4.35 | about 22.3% |
【View】You can see a very clear fact: margins have come down, but they have not collapsed; cash flow remains strong, but heavy capital expenditures have materially consumed it. 2021-2022 was a high-profit period combining the old depreciation cycle and a favorable demand window; 2023-2025 was a phase of weaker demand + new capacity buildout + higher depreciation. For long-term owners, the key is not staring at 2024-2025 EPS, but judging how much of this CapEx is "maintenance," how much is "growth," and how large the future 300mm margin leverage can be.
【Fact】On working capital, accounts receivable at the end of 2025 were $1.96 billion, up $244 million from the end of 2024; inventory was $4.81 billion, up $277 million from the end of 2024; in Q1 2026, inventory declined to $4.70 billion, and days of inventory fell from 222 days at the end of 2025 to 209 days. The company explains this as part of its effort to "build inventory ahead and maintain service levels."
【View】This data set is not a typical "financial fraud warning"; it looks more like TXN's strategic inventory. It deliberately uses a broad product line with long life cycles and low obsolescence risk to maintain inventory and supply capability during a weaker cycle, in exchange for service levels and future share. The risk is that if demand recovery is slower than expected, high inventory will continue to tie up cash and increase pressure from write-down reserves and depreciation absorption.
【Fact】The balance sheet is not fragile. At the end of Q1 2026, total cash (cash plus short-term investments) was about $5.10 billion, total debt about $14.05 billion, and net debt about $8.95 billion; operating profit in the quarter was $1.808 billion, interest and debt expense $141 million, and single-quarter EBIT/interest coverage about 12.8x. On an 【Inference】 TTM EBITDA basis, net debt/EBITDA was about 1.0x.
【View】This means TXN's leverage remains acceptable for "balanced but conservative" investors. What truly needs attention is this: if the Silicon Labs transaction closes as planned in the first half of 2027, management has already said it will be financed with cash plus new debt, and net leverage will rise temporarily. The good news is that TXN is not borrowing to keep the business alive; the bad news is that it is indeed using debt to capitalize future free cash flow in advance.
【View】Overall, my judgment on financial quality is: Earnings are real earnings, and cash is real cash, but "distributable cash" is temporarily suppressed by growth CapEx. Today's TXN is not a company with "pretty accounting earnings but poor cash flow"; it is more like "accounting earnings are down, operating cash flow remains strong, but a large amount of cash is being invested into future capacity." I do not see obvious aggressive accounting or high-probability earnings manipulation; but I also would not treat CHIPS incentives, tax benefits, and expansion CapEx all as permanent free cash flow.
Owner Earnings Analysis
【Fact】In 2025, TXN's operating cash flow was $7.153 billion, and capital expenditures were $4.550 billion. In its 2025 FCF note, the company stated that this metric included $335 million of cash benefits from CHIPS Act investment tax credits; at the end of Q1 2026, the balance sheet also recorded about $2.897 billion of current and long-term items related to CHIPS incentives.
I prefer using a conservative Owner Earnings framework rather than directly copying the company's reported FCF:
| Conservative 2025 Owner Earnings estimate | Amount |
|---|---|
| Operating cash flow CFO | $7.153 billion |
| Less: CHIPS-related cash benefits | $335 million |
| Equals: core operating cash flow | $6.818 billion |
| Less: estimated maintenance CapEx | $2.2 billion to $2.5 billion |
| Equals: conservative Owner Earnings | $4.32 billion to $4.62 billion |
The 【Assumption】 in this framework is that maintenance CapEx is $2.2 billion to $2.5 billion, based on 2025 depreciation and amortization of about $1.999 billion, and the company's 2026 capital management materials lowering 2026 gross CapEx guidance to around $2.0 billion to $3.0 billion, indicating that the six-year high-CapEx cycle is approaching its end. Based on the current share count of about 910.1 million shares, conservative Owner Earnings are about $4.7 to $5.1 per share; against the current share price of about $309.21, that equals roughly 61x to 66x Owner Earnings. Here I deliberately exclude CHIPS cash incentives, because they look more like policy benefits than operating cash you, as a long-term owner, can repeatedly collect with stability.
【View】So TXN's true earning power should be viewed in three layers: First, net income: about $5.0 billion in 2025; Second, reported free cash flow: about $2.94 billion in 2025, suppressed by high CapEx; Third, conservative Owner Earnings: I estimate $4.3 billion to $4.6 billion, reflecting "the distributable cash the enterprise might release if it only maintained its competitive position and stopped heavy expansion." This shows that TXN should remain a strong cash machine over the long term, but also that the current share price already places very high expectations on future cash release.
Intrinsic Value and Margin of Safety
Current Valuation, Relative Valuation, and Asset Perspective
As of May 23, 2026, TXN's share price was about $309.21, market capitalization about $282.6 billion, and TTM P/E about 52.9x. Annualizing the current quarterly dividend of $1.42 per share, the dividend yield is about 1.84%【Inference】.
Compare several high-confidence comparable metrics:
| Company | Current market cap | Current P/E | Latest/TTM FCF | Approx. P/FCF | Approx. P/B |
|---|---|---|---|---|---|
| TXN | 282.6B | 52.9x | 4.35B reported TTM | 64.9x | about 16.8x |
| ADI | 194.7B | 59.0x | 4.57B TTM | about 42.7x | about 5.8x |
| NXPI | 80.2B | 30.3x | 2.43B FY2025 | about 33.1x | about 7.7x |
| MCHP | 51.0B | GAAP negative | 0.87B FY2026 | about 58.5x | about 7.9x |
In the table above, prices and market capitalizations for TXN/ADI/NXPI/MCHP come from current market data; FCF, equity, and related data come from each company's latest official disclosures. Definitions differ across GAAP/non-GAAP, so they cannot be compared mechanically. But the high-confidence conclusion is clear: TXN is not cheap on cash flow or book value, especially for a mature and cyclical analog/embedded semiconductor business. ADI's high GAAP P/E is heavily affected by acquisition amortization, while TXN's expensiveness shows more in the degree to which the market has already paid for future cash-flow recovery.
【Inference】For TXN itself, based on current market capitalization and net debt at the end of 2026Q1, enterprise value is about $291.6 billion; using a rough TTM EBITDA estimate, current EV/EBITDA is about 34x. This is not a "value stock" valuation in the traditional sense, but a typical "high-quality compounding asset" valuation. For conservative capital, the problem is: the current yield you receive is too low. TXN's current TTM EPS implies an earnings yield of about 1.89%; based on reported TTM FCF of about 4.35B, FCF yield is about 1.54%; using my more conservative core Owner Earnings would produce an even lower yield. By comparison, the current S&P 500 earnings yield is about 3.11%, and the U.S. 10-year Treasury yield is about 4.57%.
【Fact】From an asset/liquidation value perspective, TXN is not an investment that works because "assets provide a floor." At the end of Q1 2026, total assets were about $34.393 billion, shareholders' equity about $16.778 billion, net PP&E about $12.145 billion, CHIPS-related items on the balance sheet about $2.897 billion, and total debt about $14.05 billion. This shows that, on one hand, book net assets are far from enough to support the current $282.6 billion market capitalization; on the other hand, book value also understates the replacement cost of rebuilding a similar 300mm capacity system. Therefore, the investment case for TXN must rest on "sustained high-quality cash flow," not an asset discount.
Intrinsic Value Estimate and Margin of Safety
Method 1: Owner Earnings DCF
The following valuation is 【Assumption + Inference】, not fact. I deliberately use conservative parameters and do not treat management's most optimistic narrative as the base case.
| Scenario | Starting Owner Earnings | First 10 years growth | Discount rate | Terminal growth | Corresponding intrinsic value |
|---|---|---|---|---|---|
| Conservative | about $4.8/share | 4% | 10% | 2.5% | about $90 to $130/share |
| Neutral | about $5.3 to $5.8/share | 5% to 6% | 9% | 3.0% | about $130 to $180/share |
| Bullish | about $5.8 to $6.5/share | 7% to 8% | 8.5% | 3.5% | about $180 to $240/share |
These ranges already embed several assumptions favorable to TXN: CapEx normalization, realization of 300mm margins, long-term growth in industrial/automotive/data center, and no damage to capital discipline from the SiLabs acquisition. Even so, I still find it difficult to justify the current share price as offering a clear margin of safety.
Method 2: Relative Valuation
The relative valuation conclusion is: TXN is not cheap. On high-confidence comparable metrics, TXN's current P/E is higher than NXPI's, reported FCF multiple is meaningfully higher than ADI's and NXPI's, and P/B is also far above peers. The only defense is that TXN's business quality and manufacturing barriers are genuinely stronger and scarcer, and the market is willing to pay a premium for "FCF leverage after CapEx declines." But that can explain "somewhat expensive," not "worth buying at any price."
Method 3: Asset/Liquidation Value
The asset-method conclusion is simpler: TXN is not suitable for an asset-discount purchase approach. Its value lies in decades of future cash distribution ability, product design wins, and channel compounding, not book net assets. The asset method can only tell you this is not a name where "PB looks low and liquidation covers the ticket price."
Accordingly, I give the more practical price framework below:
| Price range | Judgment |
|---|---|
| $90 to $130 | Conservative intrinsic value range |
| $130 to $180 | Reasonable intrinsic value range |
| $180 to $240 | Bullish intrinsic value range |
| $100 to $140 | Ideal buy price range |
| $140 to $200 | Acceptable hold price range |
| Above $240 | I tend to view this as a clearly overvalued range |
| Current about $309 | A clear premium to reasonable value |
【View】If you ask "is the current price cheap enough," my answer is: not enough. If you ask "is it worth waiting for a better price," my answer is: yes. If you ask "could this be a 'good company but bad price' situation," my answer is: that is exactly what it most resembles now.
Risks, Comparisons, Checklist, and Final Judgment
Risks and Contrary View
The most important risks are ranked not by news attention, but by "permanent capital loss":
Overvaluation risk. The current share price implies low earnings and cash-flow yields. If the future brings only "normal delivery" rather than "upside surprise," returns could remain mediocre for a long time. For long-term investors, this is the true principal risk.
Cycle and fixed-cost risk. The company has a high share of owned manufacturing, and CapEx and depreciation are rising; factory utilization swings will amplify margin changes. Operating margin in 2024-2025 has already fallen from 50.6% in 2022 to around 34%, showing that even an excellent enterprise can lose a large amount of profit leverage to cycle and depreciation.
Acquisition and financing risk. The Silicon Labs transaction is about $7.5 billion, planned to be completed with cash and new debt, and requires cross-border regulatory approvals plus manufacturing/channel/customer integration. Management expects $450 million of annual synergies and long-term FCF-per-share accretion, but this is still an unproven forward-looking narrative.
Customer and geopolitical risk. In 2025, one end customer accounted for 12% of revenue; at the same time, about 20% of revenue came from end customers headquartered in China, and about 50% of goods were shipped into China. If trade, tariffs, export controls, or geopolitics escalate, TXN will be affected.
Competition and technology substitution risk. Analog/embedded is not as fast-moving as advanced logic, but there are many competitors, and high-growth areas such as AI infrastructure, power management, and automotive-grade semiconductors are attracting more capital and acquisitions. ADI's latest quarter already showed strong data center and industrial orders, and it acquired Empower Semiconductor to strengthen AI power.
The strongest bear case is actually not complicated: "TXN may not be a bad investment, but it is very likely an investment at a bad price." Short sellers or cautious investors see a mature semiconductor company, a current yield below the risk-free rate, and a market using a very high multiple to buy several years of future FCF repair and the data center concept in advance. If any one of these positives materializes more slowly than expected, returns will be flattened by valuation.
There are two kinds of facts that would overturn my current judgment, in opposite directions: If the following occur over the next 2 to 3 years, I would admit "I underestimated its intrinsic value": first, after CapEx declines materially, TXN's FCF/revenue quickly returns to management's long-term target range of 25% to 35%; second, 300mm significantly lifts the central tendency of gross margin and operating margin; third, the SiLabs acquisition quickly delivers synergies without materially weakening the balance sheet. Conversely, if the following occur, I would admit "the current high-quality-business case has also weakened": first, margins still fail to improve when demand recovers; second, inventory and depreciation keep consuming cash for a long time; third, customer or China risks worsen materially; fourth, the acquisition brings high debt and low returns.
Comparison With Other Opportunities, Checklist, and Final Judgment
Compared with the strongest industry competitors, TXN's overall moat is likely no weaker than ADI's, and may be more distinctive in owned manufacturing and 300mm cost advantages; however, from the perspective of new capital allocation, TXN's current price is not clearly more attractive than ADI, NXPI, or broader indices. Compared with the S&P 500, TXN's current earnings yield of about 1.89% is below the S&P 500's earnings yield of about 3.11%; compared with the 10-year Treasury, TXN's current "cash return in hand" is lower, meaning that buying TXN today is more about buying the future than buying the present. For a portfolio allowed to hold only 5 assets, I believe TXN qualifies for the candidate pool, but at the current price it does not deserve your most precious new capital.
Investment Checklist
| Check item | Conclusion |
|---|---|
| Can I understand this business? | Pass |
| Does it have long-term stable demand? | Pass |
| Does it have a durable moat? | Pass |
| Does it have pricing power? | Pass |
| Can it generate stable free cash flow? | Pass, but must be viewed through the cycle |
| Are its returns on capital excellent? | Pass |
| Is management trustworthy? | Pass |
| Is capital allocation rational? | Pass, but the acquisition needs watching |
| Is the balance sheet solid? | Pass |
| Is valuation below intrinsic value? | Fail |
| Is the margin of safety sufficient? | Fail |
| Would I feel comfortable holding it long term? | Pass at the business level, fail at the price level |
| What key facts would make me sell? | FCF recovery failure, narrowing moat, acquisition damage to returns, more extreme valuation |
| Am I only interested because the share price rose or market sentiment improved? | Very likely worth asking myself |
Information limits / open questions: First, fully like-for-like comparisons of peer EV/EBITDA and ROIC are not sufficient, because fiscal years, GAAP/non-GAAP definitions, and acquisition amortization effects differ across companies; second, maintenance CapEx cannot be read directly from financial statements and can only be estimated using depreciation, management guidance, and the capacity cycle; third, the Silicon Labs acquisition has not yet closed, so the full pro forma capital structure and pace of synergy realization remain uncertain.
Final Investment Conclusion
【Final Rating】 Watch
【One-Sentence Investment Thesis】 TXN is a rare high-quality long-term compounder within semiconductors, but at the current price of roughly $309, what you are buying is more "the market's high expectations" than "a high margin of safety for shareholders."
【Core Bull Case】 First, the analog and embedded businesses are understandable, products have long lives, customers are diversified, and about 75% of exposure is to industrial/automotive/data center markets where long-term content is rising. Second, 300mm, owned manufacturing, direct sales channels, and an 80,000+ product portfolio form a real moat with high replication costs and strong ability to cross cycles. Third, management has long operated around FCF per share, with 22 consecutive years of dividend increases and a large long-term share-count reduction, and overall capital allocation has been excellent. Fourth, even through the 2024 downturn, the company maintained high profitability and a solid balance sheet, showing that business quality is genuinely strong. Fifth, after the CapEx cycle approaches its end, free cash flow has room to recover with leverage, which is the fundamental reason the market is willing to assign a high valuation.
【Core Bear Case】 First, current valuation is too high, and neither earnings yield nor FCF yield is attractive. Second, semiconductors remain cyclical; TXN has high owned manufacturing and heavy fixed costs, so depreciation and utilization will amplify volatility. Third, although the Silicon Labs acquisition has strategic logic, it introduces integration, financing, and regulatory risks. Fourth, customer concentration and China exposure are not fatal, but they are large enough to matter. Fifth, the market may confuse "excellent company" with "acceptable return." For conservative capital, the two are not synonymous.
【Key Assumptions】 The company can bring CapEx back to a more normal level in 2026-2028; 300mm capacity converts into meaningful cost advantages and margin recovery; industrial/automotive/data center demand sustains a medium- to long-term upward path; the SiLabs acquisition does not materially damage FCF-per-share growth or balance sheet safety.
【Fair Buy Price】 My ideal buy range is about $100 to $140 per share; if you are willing to accept more optimistic assumptions, $140 to $180 per share can still be discussed, but that is no longer a "Buffett-style margin of safety," it is a "quality-premium purchase." The basis is the Owner Earnings DCF above, the neutral value range, and conservative requirements for the semiconductor cycle.
【Target Holding Period】 More than 10 years. This company is not suitable for trading around quarterly volatility; if you invest, you should evaluate it over a full manufacturing cycle, product cycle, and capital allocation cycle.
【Expected Annualized Return】 If bought at the current price and held for the next 10 years, my subjective estimate is: conservative case 2% to 4%, neutral case 5% to 7%, bullish case 8% to 10%. These are not company guidance, but 【Inference】: even if business execution is good, the current starting valuation will significantly compress future returns.
【Maximum Drawdown Risk】 The worst case is not bankruptcy, but "buying high and making no money for years." If the market reprices TXN closer to a normal multiple for a mature high-quality industrial semiconductor company while FCF repair also falls short of expectations, a long-term share-price drawdown of 40% to 60% is not hard to imagine; in an extreme case where acquisition mistakes, a down cycle, and valuation compression occur together, losses could be larger.
【Tracking Indicators】 Suggested ongoing tracking:
Revenue growth in the three major markets: industrial, automotive, and data center;
Whether the central tendency of gross margin and operating margin recovers;
Operating cash flow and FCF/revenue;
CapEx amount and 300mm capacity utilization;
Days of inventory and receivables turnover;
Whether direct-sales mix continues to rise;
Net debt/EBITDA and interest coverage;
SiLabs transaction progress, financing cost, and synergy realization;
Major customer concentration;
Changes in China revenue and shipped-into-China exposure.
【Signals That Trigger Reassessment】 If the following occur, the thesis should be reviewed immediately: CapEx comes down but FCF still does not improve; 300mm fails to bring cost and margin advantages; industrial/automotive/data center growth remains persistently weaker than the industry; inventory stays high for a long time and turnover worsens; debt rises materially after the acquisition but cash flow per share does not improve; customer or China exposure suffers substantive damage.
【Final Recommendation】 Calmly put, TXN deserves a place on a long-term watchlist and long-term respect, but it does not deserve to be bought at any price. For an investor with a 10-year-plus horizon and a balanced but conservative risk preference, my advice is not to "chase the quality premium," but to wait for the market to give you a better price during a cycle, rate, inventory, or acquisition scare. Excellent businesses are hard to find, but buying an excellent business at a reasonable price is what long-term owners should truly do.
This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.
Full report
Sign in to read the full report
Sign up free to unlock the full text, the Baillie growth scorecard, and full-text search.
Log in / Sign up free